Higher lncRNA TUG1 expression appears to be predictive of distant metastases and advanced tumor stage and could serve as a biomarker for poor prognosis in cancers [31]; lncRNA TUG1 may stimulate the development of osteosarcoma, which can serve as a prognosis and diagnostic marker [32]. This evidence concerns the gene TUG1 and osteosarcoma.